Background While it is now apparent clinical sequelae (long COVID) may persist after acute COVID-19, their nature, frequency and aetiology are poorly characterised. There is an urgent need for prospective, robust, standardised, controlled studies into aetiology, risk factors and biomarkers to characterise long COVID in different at-risk populations and settings.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Sep 01, 2021 |
| Journal | BMJ Global Health |
| Authors | Melina Michelen, Lakshmi Manoharan, Natalie Elkheir, Hung‐Yuan Cheng, Andrew Dagens |
| DOI | 10.1136/bmjgh-2021-005427 |
| Citations | 975 |
| Source | OpenAlex |